Corrigendum: Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)

Nan Shen; Lihong Zhang; Jing Yang; Yongqiang Lin; Xinyu Liu; Xudong Cai; Juan Cao; Qiang Zhu; Xun Luo; Xin Wan; Henglan Wu; Jianming Ye; Chunyan Shan; Hua Xie; Yifan Wu; Yanping Cao; Jianmin Wang; Xiaoyong Yu; Huimin Wang; Jingdong He; Shaojiang Tian; Fenglei Wu; Xinxin Jiang; Lu Li; Li Zuo; Zhaohua Wang; Changying Xing; Xun Yin; Jianrong Zhao; Cong Ma; Gang Long; Qing Li; Yao Hu; Yifan Shi; Hong-Li Lin

doi:10.3389/fphar.2024.1495716

Corrigendum: Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)

Front Pharmacol. 2024 Oct 1:15:1495716. doi: 10.3389/fphar.2024.1495716. eCollection 2024.

Authors

Nan Shen¹, Lihong Zhang², Jing Yang³, Yongqiang Lin⁴, Xinyu Liu⁵, Xudong Cai⁶, Juan Cao⁷, Qiang Zhu⁸, Xun Luo⁹, Xin Wan¹⁰, Henglan Wu¹¹, Jianming Ye¹², Chunyan Shan¹³, Hua Xie¹⁴, Yifan Wu¹⁵, Yanping Cao¹⁶, Jianmin Wang¹⁷, Xiaoyong Yu¹⁸, Huimin Wang¹⁹, Jingdong He²⁰, Shaojiang Tian²¹, Fenglei Wu²², Xinxin Jiang²³, Lu Li²⁴, Li Zuo²⁵, Zhaohua Wang²⁶, Changying Xing²⁷, Xun Yin²⁸, Jianrong Zhao²⁹, Cong Ma³⁰, Gang Long³¹, Qing Li³², Yao Hu³³, Yifan Shi³⁴, Hong-Li Lin¹

Affiliations

¹ The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
² The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
³ Hefei First People's Hospital, Huaihe Road, Hefei, Anhui, China.
⁴ Wenzhou Integrated Chinese and Western Medicine Hospital, Wenzhou, Zhejiang, China.
⁵ Nanyang Central Hospital, Nanyang, Henan, China.
⁶ Ningbo traditional Chinese Medicine Hospital, Ningbo, Zhejiang, China.
⁷ Taixing People's Hospital, Taizhou, Jiangsu, China.
⁸ Xinghua People's hospital, Taizhou, China.
⁹ Hunan Provincial People's Hospital, Changsha, Hunan, China.
¹⁰ The First Hospital of Nanjing, Nanjing, Jiangsu, China.
¹¹ The First Hospital of Jiaxing, Jiaxing, Zhejiang, China.
¹² The First People's Hospital of Kunshan, Suzhou, Jiangsu, China.
¹³ Chu Hsien-I Memorial Hospital of Tianjin Medical University, Tianjin, China.
¹⁴ Dalian Ruikaer Renal Disease Hospital, Dalian, Liaoning, China.
¹⁵ Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China.
¹⁶ Handan First Hospital, Handan, Heibei, China.
¹⁷ Linfen Central Hospital, Linfen, Shanxi, China.
¹⁸ Shanxi Provincial Hospital of Chinese Medicine, Shanxi, China.
¹⁹ Liaoning Health Industry Group Bensteel General Hospital, Benxi, Liaoning, China.
²⁰ Nuclear Industry 416 Hospital, Chengdu, Sichuan, China.
²¹ Shiyan People's Hospital, Shiyan, Hubei, China.
²² Qidong People's Hospital Affiliated Qidong Hospital of Nantong University, Jiangsu, China.
²³ Sandun District of Zhejiang Hospital, Zhejiang, China.
²⁴ The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China.
²⁵ Peking University People's Hospital, Beijing, China.
²⁶ Taian City Central Hospital, Tai'an, Shandong, China.
²⁷ Jiangsu Province Official Hospital, Nanjing, Jiangsu, China.
²⁸ Changshu No. 2 People's Hospital, Suzhou, Jiangsu, China.
²⁹ The Affiliated Hospital of Inner Mongolia Medical University, Hohho, Inner Mongolia, China.
³⁰ Anshan Central Hospital, Anshan, Liaoning, China.
³¹ Tianjin People's Hospital, Tianjin, China.
³² Tianjin TEDA Hospital, Tianjin, China.
³³ Clinical Medical College and Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
³⁴ AstraZeneca Investment China Co., Medical Affairs, Shanghai, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2024.1398953.].

Keywords: Chinese population; hyperkalemia; real-world clinical practice; safety; sodium zirconium cyclosilicate.

Publication types

Published Erratum